BiopsyDevice
What this study is
The purpose of this study is to evaluate the feasibility and safety of using the LUMENA guidance system during clinical procedures in patients undergoing CT-guided needle Placement for kidney, liver, lymph node, abdominal mass and lung ablation/biopsy.
What's being tested
- LUMENA Guidance System
Intervention · DEVICE
LUMENA is an augmented reality needle guidance system that provides real-time visual guidance during CT-guided needle placement procedures.
Study details
- Official title
- Augmented Reality Real-Time Guidance With In-situ Feedback
- Sponsor
- Mayo Clinic
- Conditions
- Biopsy · Ablation
- Enrolling
- 10 people
- Starts
- 2026-09-17
- Est. completion
- 2028-09-16
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 90 YearsSex ALLHealthy volunteers AcceptedYou may qualify if
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female, ages 18-90 years
- Patient referred to Interventional Radiology for CT-guided needle placement for ablation/biopsy.
You can't join if
- Patients who are unable to give informed consent themselves or through their parents.
- Patients that do not fit into the gantry of the CT scanner.
- Patients who are sensitive to radiation exposure such as pregnant women.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openMayo Clinic
Jacksonville, Florida, United States
- Riley Nichols · Contact904-953-7783
- David Sella, MD · Principal investigator
Recruiting
Study team
Sponsor
Mayo Clinic
Study ID 26-002714
Principal investigator
David Sella, MD
Mayo Clinic
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.